Drug Pricing

Senators request answers on structure of “TrumpRx” and how recent drug pricing agreements will impact Medicare and Medicaid benefits  WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, this week led six Senate Democrats in demanding transparency from the…

WASHINGTON, D.C.—Finance Committee members Senator Peter Welch (D-Vt.) and Catherine Cortez Masto (D-Nev.), alongside Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today introduced the No Big Blockbuster Bailouts Act (NOBBBA), a bill to reverse Republicans’ policies in the so-called ‘One Big Beautiful Bill Act’…

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.) today joined U.S. Senators John Cornyn (R-Texas), Jacky Rosen (D-Nev.), and Thom Tillis (R-N.C.) in introducing the Share the Savings with Seniors Act of 2025, which would lower out-of-pocket prescription drug costs for seniors with chronic health…

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.) today celebrated the White House’s announcement that it has selected 15 additional prescription drugs for Medicare price negotiations. These newly announced prescription drugs—together with ten drugs already negotiated last year—represent nearly a third of all Medicare Part…

Bill paves the way for more generic drugs to come to market  WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.) joined Senators John Hickenlooper (D-Colo.), Tom Cotton (R-Ark.), and Susan Collins (R-Maine) recently to introduce the bipartisan Skinny Labels, Big Savings Act, legislation designed to…